TNF Blockers May Help Some With Rheumatoid Arthritis
If standard treatment fails, more intensive therapy works well, study finds THURSDAY, Aug. 6 (HealthDay News) -- Patients with early rheumatoid arthritis (RA) who respond poorly to standard treatment with methotrexate may benefit from additional treatment with tumor necrosis factor (TN...Questions Continue About Using Beta Blockers Before Surgery
Study finds increased risk of death, heart attacks MONDAY, Oct. 20 (HealthDay News) -- A new study adds to doubts about using beta blockers to reduce the risks of surgery. The death rate for people given beta blockers before non-cardiac surgery was 10 times higher in the 30 days aft...Beta Blockers Help Hospitalized Heart Failure Patients
Continuing treatment reduces death risk, rehospitalization rates, study finds FRIDAY, July 11 (HealthDay News) -- People who are hospitalized for severe heart failure and have been taking beta blockers should be kept on those medications while in the hospital, a new study finds. And...Beta Blockers Raise Stroke, Death Risk After Surgery
Experts note doses of the blood-pressure drugs given in the study were probably too high TUESDAY, May 13 (HealthDay News) -- Patients who received the blood pressure-lowering drugs known as beta blockers after having non-cardiac surgery were at higher risk of dying or having a stroke, ...Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells
The study was published online February 5 in the February 2008 edition (Volume 6, Issue 2) of the journal PLoS Biology. The research team found that the hypertension drugs diltiazem and verapamil increased the overall function of mutant lysosomal enzymes associated with the conditions Gaucher d...Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), issued a statement in response to the Food and Drug Administration (FDA) announcement regarding the results of a safety rev...Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
Beta blockers have been used widely in the treatment of hypertension and are still recommended as first-line drugs in hypertension guidelines. Moreover, after myocardial infarction and in patients with heart failure, treatment // with beta blockers prevents re-infarction, hospitalisation for heart ...Angiotensin-II-receptor blockers - Treat kidney failure
Drugs used to treat high blood pressure have been found to also help slow the progress of kidney failure. Three separate drug trials reveal that the angiotensin-II-receptor blockers, which include losartan and irbesartan, can be used to treat kidney failure, one of the commonest complications in di...Fish Oils May Prevent and Treat Heart Disease
...ial, and the patients in the trial were already getting intensive drug therapy including clot-busting clopidogrel, cholesterol-lowering statins, beta blockers and ACE inhibitors, Lavie noted. Set against that one trial are the many larger studies cited by Lavie, and epidemiological evidence showing that p...Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA
...nnounced that it has completed its analysis of TNF blockers and has concluded that there is an increased risk ...oxed warning for these products," she said. TNF blockers already carry FDA-mandated warning labels for oth...g these drugs should: Be aware that taking TNF blockers may increase the risk of developing lymphoma, leuk...Research: Popular Diabetes Medications Associated with Increase in Bone Fractures
... clopidogrel alone. Communications with Doctors Increase Use of Key Medications in Diabetes Ace Inhibitors (ACE-I) and angiotensin receptor blockers (ARB), two major categories of antihypertensives, appear to have unique clinical benefits compared to other antihypertensive therapies. New Medco res...Vantia Therapeutics' Pipeline Continues to Mature
...th at least 70% of BPH patients complaining of nocturia. Whilst some symptoms of BPH are successfully addressed by the standard BPH therapies of alpha blockers and 5-alpha reductase inhibitors, nocturia remains inadequately treated. With estimates putting the number of BPH/nocturia sufferers at 55 million in ...Research Finding Could Revolutionize Asthma Treatment
... Use of Beta blockers May Have Long-Term Benefits SAN FRANCISCO, Fe...sthma Foundation (AAF), said, "Drugs known as beta blockers have long been used to treat high blood pressure. ... and his colleagues showing that low doses of beta blockers improved asthma in mice. Expanding on his des...2 beta blockers found to also protect heart tissue
DURHAM, N.C. A newly discovered chemical pathway that helps protect heart tissue can be stimulated by two of 20 common beta-blockers, drugs that are prescribed to millions of patients who have experienced heart failure. Researchers from Duke University Medical Center tested 20 beta blockers a...UC Davis grant zeroes in on novel asthma diagnosis and treatment
... researchers have demonstrated that sEH inhibitors are strongly synergistic with current asthma drugs: cycloxygenase inhibitors and several of the blockers of leukotriene biosynthesis. "We hope to both evaluate sEH inhibitors alone in treating asthma but also to combine them with other inflammatory ...Limping rat provides sciatica insights
...y, or limping, which could prove important as we evaluate different treatments." Further studies are planned to test the effects of different IL-17 blockers on the mechanics of the animals' movement. ...Targeted drug therapy prevents exercise-induced arrhythmias
...c deaths in young athletes. Current treatment has been limited to two medications beta blockers, often used at very high doses, and calcium channel blockers to control the arrhythmias. Implantable cardioverter defibrillators (ICDs) are placed in patients at high risk for sudden death, but ongoing arrhyth...Researchers may have found why women have an edge on salt-sensitive hypertension
... in the kidney's tubules and vasculature while colleagues at the University of Edinburgh in Scotland are beginning studies to look at how ETA receptor blockers impact sodium excretion in humans. ...New asthma research opposes current drug treatment, says UH prof
...entually improving their overall health. Beta blockers currently are contraindicated for asthma because t.... Bond has suggested, however, that although beta blockers would not replace the need for emergency inhalers ...pisodes, the negative effects associated with beta blockers eventually taper off to provide long-term relief f...Gene therapy reversed heart damage in heart failure
... not reversed, with the concomitant metoprolol. "Our data show that beta blockers and the ARKct peptide are compatible and can be given together," Dr. Koch said. "Although beta blockers are effective at stopping the downward progression of the disease, they do ...Vitiligo skin disorder could yield clues in fight against melanoma
... Le Poole hopes to throw a wrench into this overactive immune response. In collaboration with Assay Designs, Inc. of Ann Arbor, Mi., she is developing blockers that would stop immune cells from absorbing stress hormones and triggering the immune response. "An active immune response can be bad for vitiligo ...Duke Medicine physician-scientist receives National Medal of Science
...the membranes surrounding cells, are the targets of almost half of the drugs on the market today, including antihistamines, ulcer medications and beta blockers for heart disease. Lefkowitz and his group first identified, purified and cloned the genes for these receptors in the 1970s and 1980s, thus revealing ...Blood pressure response to daily stress provides clues for better hypertension treatment
... an hour of stress, a few minutes of relief, then back to stress by getting the young people to play competitive video games, then measuring how gene blockers affect sodium excretion. "Ultimately, you want to know how to treat people with this variation," Dr. Harshfield says. "There is still a need to figur...SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS
Development activities are intended to support regulatory filings for S0812 and additional promising bitter blockers SAN DIEGO, CA, February 9, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a leading company focused on using proprietary technologies to discover and develop n...SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
...ancers, Senomyx had notable progress in its Bitter blockers Program during the past quarter. Recent taste tests demonstrated that the Company's bitter blockers can provide statistically significant reductions i...ocused development activities for promising bitter blockers are underway. "Reducing bitterness would b...SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS
...ctivities to support regulatory filings for Bitter blockers S0812 and S6821 SAN DIEGO, CA, May 7, 2009 /P...h Solae on the discovery and development of bitter blockers that modulate and control bitterness in certain soy-based products. New bitter blockers discovered by the Company provided a taste proof-o...SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
...ities to support regulatory filings for new Bitter blockers - Receipt of GRAS (Generally Recognized As Sa...atory filings for S0812 and other promising bitter blockers that met the criteria established by our partner. ...am. The Company identified S0812 and other bitter blockers that met the criteria for reducing the bitterness ...Inverseon's Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet
...was published in the January 10, 2009 issue of The Lancet. "To our knowledge, this would be the first patent for the utilization of certain beta blockers for the treatment of asthma," commented Amie E. Franklin, PhD, of Inverseon. "A similar story played out 10 years ago in congestive heart failure wher...Lilly Completes Cash Tender Offer for ImClone Systems
...atments designed to address the medical needs of patients with a variety of cancers. ImClone's research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone's headquarters and research operations are located in New York City, with additional administration and manufactu...SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
...n collaboration with Solae to develop bitter blockers that improve the taste of hydrolyzed soy protein ... in the companies' collaboration to develop bitter blockers that improve the taste of certain soy-based produc...emonstrating the ability of S5105 and other bitter blockers to provide a statistically significant reduction i...